CA
NZ
UK
AU
IND
US
• IBio’s IBIO-610 reduced active Activin E levels by 98% at week 4 in obese non-human primates after a single dose.
• INmune Bio Inc. (NASDAQ: INMB) reduces the exercise price of certain warrants to $1.40, down from $1.95.
• Martin J. Bonick has officially stepped down from his role as President and CEO of Ardent Health, effective June 2, 2026.
• The company has made leadership transitions to drive strategic initiatives and enhance corporate governance.
• The company filed the update with the U.S. Securities and Exchange Commission.
• The funds will primarily refinance $350 million of existing 4.250% Senior Notes due in October 2026.
• Olsoni will serve on the Audit Committee, underscoring his role in financial oversight.
• No significant difference in mortality rates was observed between Vafseo and ESA, with rates of 8.77% and 8.78% per 100 patient years, respectively.
• Allarity Therapeutics reported 8,364,272 shares, representing 54.10% voting presence at its annual shareholder meeting.
• Allurion Technologies (NYSE: ALUR) director R. Jason Richey resigned as audit committee chair effective June 24, 2026.
Please wait processing your request...